×

RNS Number : 2119G

Solid State PLC

14 November 2022

 

 

Reach – non regulatory announcement

 

Solid State plc

( "Solid State", the " Group " or the "Company" )

£7.3m Defence Contract with NATO

 

Solid State plc (AIM: SOLI), the specialist value added component supplier and design-in manufacturer of computing, power, and communications products, announces that it has been awarded a £7.3m contract by the NATO Support and Procurement Agency (NSPA) to supply communications equipment to a defence customer through its Systems division.  Delivery is expected within the current financial year, which will contribute towards achieving current market expectations.

 

Commenting on the contract, Matthew Richards, MD of the Systems division, said:

"In our AGM statement we referenced the strength of the defence sector, so it is pleasing to be announcing this award with such a significant client.  The Group has a good reputation in the delivery of high reliability technology for ruggedised applications so this customer requirement fitted very well."

 

For further information please contact:

 

Solid State plc Gary Marsh – Chief Executive Peter James – Group Finance Director	Via Walbrook
Walbrook PR (Financial PR)  Tom Cooper / Nick Rome	020 7933 8780 0797 122 1972 [email protected]

 

 

Analyst Research Reports: For further analyst information and research see the Solid State plc website: https://solidstateplc.com/research/

 

Notes to Editors:

Solid State plc (SOLI) is a value added electronics group supplying commercial, industrial and defence markets with durable components, assemblies, manufactured units and power units for use in specialist and harsh environments.  The Group's mantra is – 'Trusted technology for demanding environments'.  To see an introductory video on the Group –  https://bit.ly/3kzddx7  

 

Operating through two main divisions: Systems (Steatite, Active Silicon & Custom Power) and Components (Solid State Supplies, Pacer, Willow Technologies & AEC); the Group specialises in complex engineering challenges often requiring design-in support and component sourcing for computing, power, communications, electronic, electro-mechanical and opto-electronic products.

 

Headquartered in Redditch, UK, Solid State employs approximately 400 staff across the UK and US, serving specialist markets with high barriers to entry in industrial, defence and security, transportation, medical and energy. 

 

Solid State was established in 1971 and admitted to AIM in June 1996.  The Group has grown organically and by acquisition – having made 4 acquisitions in the last 5 years.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

NRAFZMMMNMVGZZM

Close

×

RNS Number : 5924F

Touchstar PLC

08 November 2022

 

This announcement contains inside information for the purposes of Article 7 of the UK version of Regulation (EU) No 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended ("MAR"). Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

 

8 November 2022

 

Touchstar plc

("Touchstar", the "Company" or the "Group")

Contract Award

 

Touchstar plc (AIM:TST), suppliers of mobile data computing solutions and managed services to a variety of industrial sectors, is pleased to announce that  it has won a substantial order from a Petrochemical Distribution client (Touchstar's largest market) to upgrade them to Touchstar's latest cloud-based solution. The contract award is worth in excess of £1.5m in the first twelve months with subsequent years benefitting from recurring revenues under a multiyear licencing and support agreement.

 

Following this award, the Company's order book stands at £2.3 million a significant increase on the £1 million reported in the Company's interim results released on the 15 September 2022.

 

This contract award and order book level reinforces our expectations for FY2022 and FY2023 and that the uptick in activity we have seen in the Petrochemical Distribution sector will continue and develop into further order intake.

 

 

For further information, please contact:

 

Touchstar plc Ian Martin Mark Hardy	www.touchstarplc.com 0161 874 5050 0161 874 5050
WH Ireland – Nominated Adviser & Broker Corporate Finance – Mike Coe/Sarah Mather	www.whirelandcb.com 020 7220 1666

 

Information on Touchstar plc can be seen at: www.touchstarplc.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

CNTGZMGMRNNGZZM

Close

×

RNS Number : 5993F

Light Science Tech. Holdings PLC

08 November 2022

 

Light Science Technologies Holdings plc

("LSTH", the "Company" or the "Group")

 

Additional sensorGROW trials and nurturGROW update

 

· Additional trials secured for sensorGROW with potential roll-on subscriptions worth up to £167,000, over a three-year period

· PCT patent filed with Intellectual Property Office for nurturGROW tuneable luminaire

 

sensorGROW trials

Light Science Technologies Holdings plc (AIM: LST), the controlled environment agriculture ("CEA") technology and contract electronics manufacturing ("CEM") group, is pleased to announce that it has signed two further trial contracts for its recently launched sensorGROW product.

 

If successful, the trial contracts, which include one with a leading UK manufacturer of preserves, marmalades and associated products , could roll into subscriptions and be worth up to £167,000 in recurring revenues over a three year period. These trials are in addition to the ones announced on 22 September 2022, which are potentially worth up to £940,000.

 

The Group remains in talks with a variety of other growers regarding sensorGROW trials.

 

PCT Patent filed with Intellectual Property Office for nurturGROW tuneable luminaire

The CEA division has filed a PCT patent with the Intellectual Property Office for its nurturGROW 'tuneable' luminaire, featuring its pioneering LED grow lighting technology.

 

This allows any CEA grower the means to adjust both the lighting output to optimise energy costs and also adjust and precisely tune the light emission spectrums to suit a crop's growth cycle which in turn allows the grower to choose the light recipe for a variety of crops. This level of control is achievable at the touch of a button through nine independently controlled circuits within its patented modular luminaire.

 

Ideal for vertical farms and other multi-layer growth applications, the luminaire's slimline design is specifically suited for use in a closed, climate controlled growing facility and can maximise space, thanks to its lower profile and bespoke length. 

 

Simon Deacon, CEO and founder of Light Science Technologies, said : " The Company remains focused on growing recurring revenues by providing technology, data collection, advisory and maintenance services for clients. We have a strong and growing product range that is aimed at broadening routes to market and strengthening cross-selling opportunities. We very much look forward to providing further updates in due course as we build on recent momentum."

 

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014, as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 (as amended).

 

For further information, please contact:

 

Light Science Technologies Holdings plc	www.lightsciencetechnologiesholdings.com
Simon Deacon, Chief Executive Officer Jim Snooks, Chief Financial Officer Andrew Hempsall, Chief Operating Officer	via Walbrook PR
Strand Hanson Limited (Nominated & Financial Adviser)	Tel: +44 (0) 20 7409 3494
Ritchie Balmer / James Harris / Rob Patrick
Turner Pope Investments (TPI) Ltd (Broker)	Tel: +44 (0) 20 3657 0050
James Pope / Andy Thacker
Walbrook PR Ltd (Media & Investor Relations)	Tel: +44 (0)20 7933 8780 or  [email protected]
Nick Rome / Paul McManus

About Light Science Technologies Holdings plc (www.lightsciencetechnologiesholdings.com)

Light Science Technologies Holdings plc is the holding company of the Group's controlled environment agriculture ("CEA") division, Light Science Technologies Ltd ("Light Science Technologies"), and its contract electronics manufacturing ("CEM") division, UK Circuits and Electronics Solutions Limited ("UK Circuits").

 

Controlled Environment Agriculture

Light Science Technologies was founded in 2019 and is the Company's grow lights and sensor technology business, providing bespoke recipes and technologies tailored to customers' needs – with key targets including indoor, vertical, glasshouses, polytunnels and medicinal farming markets. The all-in-one CEA solution will include analysing customers' crop growing requirements to provide bespoke, low-energy and sustainable equipment.

 

Market drivers include food and water shortages in many parts of the world; growing global population; UK and other government policy encouraging sustainable and efficient growth methods; increased scrutiny of the effect of food production on climate change and the continuing transition away from processed foods. 

 

sensorGROW

sensorGROW was launched in June 2022 and its technology will enable farmers to monitor the following key air zone growing factors in real-time: carbon dioxide levels, humidity, light, oxygen – and in the future: air speed, plant disease, soil, temperature and water pH levels. By monitoring these key growing factors, farmers can save money through better management of resources: water, nutrients, fertilisers and energy – while increasing yields and producing healthier crops.

 

nurturGROW

nurturGROW is a sustainable grow lighting product range, offering an innovative, high-performance and cost-effective solution for indoor farming, covering greenhouses, vertical farming, polytunnels and medicinal plants.

 

Created with four core component parts, the nurturGROW range is made of high quality, durable materials to give growers the ideal balance between strength and optimal performance, minimising the amount of materials needed to drastically cut down on waste and reduce carbon footprint.

 

 

 

Contract Electronics Manufacturing

UK Circuits is the Company's CEM focussed division, profit making with strong revenues. The Group designs, procures, and manufactures high-quality CEM products, specialising in Printed Circuit Boards, which are used in a range of sectors including audio, automotive, electronics, gas detection, lighting, pest control, telecommunications and, more recently, the CEA market.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

MSCEAEFXEFKAFAA

Close

×

RNS Number : 1393F

4GLOBAL PLC

03 November 2022

 

3 November 2022

4GLOBAL PLC

("4GLOBAL" or the "Company")

Sports Event Contract Win

4GLOBAL, a UK-based data, services and software company focused on sport and the promotion and measurement of physical activity, is pleased to announce a successful contract win to provide operational support in the lead up to, and for the duration of, a major sporting event taking place this year.

4GLOBAL has been retained to provide operational assistance to ensure the host nation is prepared for the upcoming major football sporting event scheduled to take place in late-November and conclude in mid-December. The contract value is approximately £200k.

This project has enabled 4GLOBAL to further strengthen its strategic partnership in the region with Al Jassra Group – an international conglomerate with revenues exceeding £1bn globally – which is a long-term partnership in this marketplace that has generated potential multi-million pound active tendering opportunities for 4GLOBAL. 

Eloy Mazon, 4GLOBAL's CEO, commented:

"We are pleased to be further expanding our service offering and assisting with the upcoming event in a collaborative process as we work to ensure the host nation's readiness prior to and during the upcoming tournament .

"This project has given us an opportunity to continue our expansion in the middle eastern market through strategic partnerships which is key to our growth in the region. We are delighted to continue strengthening our partnership with Al Jassra which is major player in the region and internationally.

"The international demand for our products and to partner with 4GLOBAL in projects is allowing us to accelerate our expansion into other international markets which is a key pillar of our growth strategy"

 

For further information please contact:

4GLOBAL   Eloy Mazon (CEO)	c/o IFC Advisory
Spark Advisory Partners – Nominated Adviser   Neil Baldwin	0203 368 3554
Oberon Capital – Broker   Michael Seabrook, Adam Pollock, Chris Crawford	0203 179 5300
IFC Advisory   Graham Herring / Zach Cohen	0203 934 6630 07793 839 024

 

About Reach announcements

Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases such as marketing messages, corporate and product information into the public domain. An RNS Regulatory announcement is required to be notified under the AIM Rules for Companies.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

NRABIBDBRXGDGDD

Close

×

RNS Number : 4107E

Plant Health Care PLC

28 October 2022

 

RNS

28 October 2022

 

PLANT HEALTH CARE plc

("Plant Health Care" or the "Company")

 

Distribution agreement for commercial sales in Europe 

 

EDAF Selected as Distributor in Portugal

 

Plant Health Care®(AIM: PHC.L), a leading provider of novel patent-protected biological products to global agriculture markets, has signed an agreement for EDAF Unipessoal LDA ("EDAF") to become the exclusive distributor in Portugal for its proprietary PREtec-containing fertilizer, PREzym™, for use in fruit, vegetable and cereals crop production.

 

The Company expects to commence commercial sales of PREzym in the first half of 2023. Plant Health Care and EDAF have been working together since 2016 when EDAF became the exclusive distributor in Portugal of the Company's proprietary ProAct® plant health product. Today's announcement further strengthens the partnership and will help Plant Health Care fulfill its ambitious plans to grow its global footprint/market share across Europe.

 

Derived from natural proteins, PREtec is an environmentally friendly technology which stimulates crop growth and ability to withstand a variety of abiotic stresses to improve plant health and yield. PREtec is compatible with mainstream agricultural practices.

 

Plant Health Care continues to expand into new markets around the world and is growing its relationships with major global distribution partners. The Company is on track to achieve revenue of $30 million by 2025 through the launch of new products and continued organic business growth through current and future distributor relationships.

 

This announcement marks the first sales of PREtec-based products into Europe and supports farmers seeking to use more sustainable practices.  Europe is fast becoming one of the largest markets for sustainable biological products and PREtec-containing products will help produce higher crop yields locally to address the global food supply crisis.

 

Jeff Tweedy, CEO of Plant Health Care,  said: ‟Today's announcement marks a significant milestone for Plant Health Care and our ambitious plans to grow our global footprint/market share. I am excited for our first sales of the PREtec technology in Europe which has the potential to grow considerably and transform the European farming industry towards a sustainable future with better crops delivering a higher yield for thousands of farmers.  EDAF has proven to be a strong partner over the years, supporting the growth of PHC's products in Portugal.

 

Pedro Tavares, CEO of EDAF Unipessoal Lda,  said:"Plant Health Care is a reliable partner, with cutting-edge technology and always looking for sustainable solutions for an increasingly demanding market, which allows for differentiated and technologically advanced products. This agreement aligns with our strategy to supply an innovative and high-quality portfolio to our customers and is responsive to the increasing demand for sustainable solutions. EDAF, LDA and its technical team would like to thank Plant Health Care for all the trust placed in it to develop and commercialize PREtec in Portugal"

 

For further information, please contact:
 

Plant Health Care plc Jeff Tweedy, CEO	+1 919 926 1600
Cenkos Securities plc – Nomad & Broker Neil McDonald / Pete Lynch	+44 (0) 131 220 9771
SEC Newgate (Financial Communications) Robin Tozer / Richard Bicknell / George Esmond	+44 (0)7540 10666 [email protected]

 

 

 

About Plant Health Care

Plant Health Care offers products to improve the health, vigour and yield of major field crops such as corn, soybeans, potatoes and rice, as well as specialty crops such as fruits and vegetables. We operate globally through subsidiaries, distributors and supply agreements with major industry partners. Our innovative, patent-protected biological products help growers to protect their crops from stress and diseases, and to produce higher quality fruit and vegetables, with a favourable environmental profile.

 

 

About EDAF Unipessoal LDA

EDAF focuses on representing and developing innovative/non residue high quality products for the portuguese agricultural markets. By providing qualified technical assistance, EDAF offers innovative solutions to growers all year around.

 

Find out more at  www.planthealthcare.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

AGRFEUFWWEESEFS

Close

×

RNS Number : 7747D

Proton Motor Power Systems PLC

24 October 2022

 

Prior to publication, the information contained within this announcement was deemed by the Company to constitute inside information, as stipulated under the UK Market Abuse Regulation. With the publication of this announcement, this information is now considered to be in the public domain.

 

24 October 2022

 

Proton Motor Power Systems plc

("Proton Motor" or the "Company")

 

New production facility to significantly expand manufacturing capability

 

Proton Motor Power Systems plc (AIM: PPS), a leading designer, developer and producer of fuel cells and fuel cell electric hybrid engines with a zero-carbon footprint, announces that it has signed a fifteen-year lease agreement for a modern 13,500m2 facility (the "Facility") that will be used to substantially expand the Company's manufacturing, testing and development capacity.

 

Proton Motor has been developing its fuel cell technology since 1998 to be probably one of the leading fuel cells in industrial, long-lifetime markets. There is an increased political awareness that hydrogen and fuel cells will play a fundamental role to overcome the climate energy crisis and this is expected to lead to an increased demand for fuel cells. In anticipation of this increased demand for the Company's products, Proton Motor intends to increase its annual production capacity to 5,000 fuel cell hydrogen engines and up to 30,000 fuel cell stacks.

 

The Facility will supplement the Company's current 6,000m2 site in Puchheim, Germany, which will now become the development facility for stacks and hydrogen engines. The new Facility is located in the town of Fürstenfeldbruck, located c. 12km from Puchheim and is contained within the Munich metropolitan region. The Facility will be used for serial manufacturing and will also be the location of the Company's sales and marketing teams, as well as the maintenance and training centre.

 

The total land surface of the Facility is 25,700m2 and it contains over 13,500m2 of useable space, of which over 10,500m2 can be dedicated to production, testing and development. The remainder of the space will be devoted to office usage. This represents a seven-fold increase in the amount of space available for production when compared to the Company´s current premises.

 

Concurrently with the enhancement of production capacity, the Directors of Proton Power have determined that the Company will be enlarging the sales department in order to meet the anticipated increase in demand.

 

Dr. Faiz Nahab, Chief Executive Officer of Proton Motor, stated: "Hydrogen is the energy storage source of the future and awareness of this is increasing to a considerable extent both amongst the public and within industry. This creates a strong market-pull for associated technologies such as fuel cells. This is evidenced by discussions with existing customers for midterm batch orders. With this background, the additional space provided by the new Facility will give Proton Motor the required capacity to produce, test and deliver fuel cell hydrogen engines in line with this anticipated growing demand."

 

 

 

For further information:

 

Proton Motor Power Systems Plc
Dr Faiz Nahab, CEO
Helmut Gierse, Chairman
Roman Kotlarzewski, CFO	+49 (0) 173 189 0923
Antonio Bossi, Non-Executive Director
Investor relations:	www.protonpowersystems.com
inv[email protected]
Allenby Capital Limited
Nominated Adviser & Broker	+44 (0) 20 3328 5656
James Reeve / Vivek Bhardwaj

 

About Proton Motor Fuel Cell GmbH

 

Proton Motor has more than 20 years of experience in Power Solutions using CleanTech technologies such as hydrogen fuel cells, fuel cell and hybrid hydrogen engines with a zero carbon footprint.  Based in Puchheim near Munich, Proton Motor offers complete fuel cell and hybrid hydrogen engines  from a single source – from the development and production through the implementation of customized solutions.  The focus of Proton Motor is on back-to-base, for example, for mobile, marine and stationary solutions applications.  The product portfolio consists of base-fuel cell hydrogen engines, standard complete hydrogen engines, as well as customized hydrogen engines .

 

Proton Motor serves IT, Telecoms, public infrastructure and healthcare customers in Germany, Europe and Middle East with power supply solutions for DC and AC power demand.

 

Proton Motor Fuel Cell GmbH is a wholly owned subsidiary of Proton Motor Power Systems plc. The Company has been quoted on the AIM market of the London Stock Exchange since October 2006 (code: PPS).

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

MSCBKDBPPBDDBKB

Close

×

RNS Number : 5550C

S-Ventures PLC

12 October 2022

 

12 October 2022

 

S-VENTURES PLC

("S-Ventures" or the "Company")

AQSE Ticker Code: SVEN

Market Rocket launches new full service offer

S-Ventures PLC, the Company investing in and growing exciting brands across the natural, wellness and food-tech category, is pleased to announce Market Rocket, the Amazon growth specialists owned by S-Ventures, has launched its new full service digital marketing and PR offer following the recent acquisition of two digital marketing agencies.

Since 2019, Market Rocket, has delivered transformative D2C business growth to more than 100 global industry leaders (including brands such as Calvin Klein, Tommy Hilfiger and JCB) across the Amazon ecosystem, earning the platform's SPN (Service Provider Network) accreditation, but will now offer clients a complete digital marketing and PR service.

Combining more than 50 years of experience in driving sales growth via Amazon, Market Rocket has now acquired strategic digital marketing specialists Mapped Marketing and award winning PPC and SEO agency Bugbear Marketing.

The deal, announced this month, positions Market Rocket as the ideal launch pad for big brands, founder-owned market-disruptors and start-ups alike to achieve business growth through specialist website development, SEO performance, on-trend social media engagement, digital marketing and PR, to add to its broad D2C and ecommerce expertise.

Market Rocket Founder and Managing Director, Matthew Peak, commented: "We firmly believe that amalgamating Market Rocket's proven ability to deliver ROI on Amazon with the specialist SEO, PPC, website design, and PR skills provided by the other agencies mean that these acquisitions will help us to create a truly unique offering to some of the world's largest brands and newest market-disruptors."

S-Ventures CEO, Scott Livingston, commented: "We are delighted with the progress Market Rocket has made with the latest acquisitions of two digital marketing agencies and subsequent new full service digital marketing and PR offering. Our focus on quality across our product range underpins our success and we look forward to further progress in the coming months."

www.marketrocket.co.uk

For further information, please contact:

The Company Robert Hewitt (Chief Financial Officer) Scott Livingston (Chief Executive Officer)	+44 (0) 1932 400 224
AQSE Corporate Adviser and Broker: VSA Capital Limited Andrew Raca – Corporate Finance Andrew Monk – Corporate Broking	+44 (0) 20 3005 5000
IFC Advisory (Financial PR) Graham Herring Tim Metcalfe Florence Chandler	+44 (0) 20 3934 6630

 

About S-Ventures

S-Ventures is listed on UK AQUIS Exchange (Ticker Code "SVEN"). The Company seeks to identify investment opportunities in the health & wellness, organic food and wellbeing sectors within the UK and Europe, adding value by providing capital and expertise to the target companies. The experience and operational skills of the Board led by Scott Livingston (CEO) are intended to act as an accelerator to smaller brands that have a solid foundation and platform but may lack the skills and capital. The main objectives are to cross-fertilise opportunities between the target companies and scale the individual entities and look for exit opportunities and/or synergistic collaborations through scaling we seek to create significant value for all stakeholders. Since listing on AQSE in September 2020, the Company has acquired significant interests in seven companies.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

NEXMBBPTMTMBBLT

Close

×

RNS Number : 9412B

AMTE Power PLC

06 October 2022

 

Thursday 6 October 2022

 

AMTE POWER PLC

("AMTE Power", "AMTE" or the "Company")

AMTE Power agrees production contract with the UK Battery Industrialisation Centre for its Ultra High Power cells

 

Highlights:

·     Milestone achievement: framework contract signed with the UK Battery Industrialisation Centre ("UKBIC") to produce up to 60,000 Ultra High Power cells per year for the high power automotive and fuel cell electric vehicle markets

 

·     Ultra High Power automotive cell demonstrates a consistent six-minute full charge time in extensive trials

 

·     The contract with UKBIC starts in January 2023 for anticipated sales to customers in sufficient scale to allow them to progress to in-vehicle trials

 

·     Agreement is a key milestone to upscale production ahead of mass commercialisation plans as AMTE Power progresses towards its first MegaFactory in Dundee, Scotland, which is underpinned by the growing pipeline of potential business with opportunities of circa £240 million across the AMTE Power product range

 

AMTE Power moves to scale manufacturing at the UK Battery Industrialisation Centre

AMTE Power, the developer and manufacturer of lithium-ion and sodium-ion battery cells for specialist markets, announces that it has signed a contract to manufacture its Ultra High Power cells at UKBIC in Coventry to support the next phase of its commercialisation plans.  

This is a significant milestone for AMTE Power. Under the agreement the Company can request UKBIC to manufacture up to 60,000 of its Ultra High Power cells each year, over an initial term of 24 months.  This will enable AMTE Power to deliver its first Ultra High Power cells, in sufficient scale to allow customers to progress through to in-vehicle trials, as the industry transitions away from traditional fuels.

In August 2022, AMTE Power announced good progress in manufacturing trials for the Ultra High Power cell at UKBIC, with cells performing well against the Company's target specification when produced on UKBIC's commercial scale equipment.  In particular, the Ultra High Power cells' low internal resistance supports exceptional power delivery and very fast charging, with current testing demonstrating a full charge in six minutes.

Ramping up production of the Ultra High Power cells at UKBIC is due to start from January 2023, generating initial revenues for the Company and enabling the business to meet growing demand from within the automotive sector principally for high performance Electric Vehicles ("EVs") and Fuel Cell Electric Vehicles ("FCEVs"). AMTE Power has existing non-binding memoranda of understanding in place with key automotive partners Cosworth, Viritech and MAHLE Powertrain, in addition to development agreements with Sprint Power, Eltrium and BMW.  

The use of UKBIC to manufacture cells is a key milestone to upscale production ahead of mass commercialisation plans as AMTE Power progresses towards its first MegaFactory in Dundee, Scotland. This agreement will ensure products can be delivered to customers in advance of the opening of its planned MegaFactory, which is underpinned by the growing pipeline of potential business with opportunities of circa £240 million across the AMTE Power product range.

Commenting on the contract, Kevin Brundish, CEO, AMTE Power, said:

"Having already secured significant early interest in our Ultra High Power cell from major automotive partners, this contract will enable us to bring our products to market sooner while we progress our own MegaFactory.

"This new phase in our journey builds on the partnership that we've established with UKBIC through cell development. It is testament to the investment that the UK Government has made in this market-leading battery manufacturing and scale-up facility that we are now able to put that development work into practice with the first production contract at UKBIC to get cells into customers' hands as we power the energy transition."

Jeff Pratt, Managing Director, UK Battery Industrialisation Centre, added:

"We're delighted to be entering into this landmark agreement with AMTE Power to transfer their design into UKBIC and then manufacture their next generation Ultra High Power cells at volume, allowing us to further support the company's significant commercialisation plans. Advanced battery cells being manufactured at volume in the UK are a vital component of ensuring the UK prospers from the energy transition towards Net Zero. This latest agreement – our biggest to date – is further demonstration of the unique value of UKBIC which, since being opened just over a year ago, is already delivering incredibly successful outcomes for the UK with customers like AMTE."

Jackie Doyle-Price, Minister for Industry said: 

"Batteries are the foundation of the industries of the future, from electric vehicles to renewables, and building a domestic supply chain for them is central to our plans to grow the economy, create jobs and bolster energy security.

"This collaboration between two government-backed partners will see AMTE's battery production ambitions take the next step, and help the UK seize on the opportunities this technology presents." 

 

This announcement contains inside information for the purposes of Article 7 of the UK version of Regulation (EU) No 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended ("MAR"). Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

 

ENDS

Enquiries:
AMTE Power plc	Tel: +44 (0)1847 867 200
Kevin Brundish (Chief Executive Officer)
James Hobson (Chief Financial Officer)
WH Ireland Limited (NOMAD and Joint Broker)	Tel: +44 (0)207 220 1666
Chris Fielding / James Bavister / Ben Good
Panmure Gordon (UK) Limited   (Joint Broker)	Tel: +44 (0)207 886 2500
John Prior / Harriette Johnson (Corporate Finance) James Sinclair-Ford Hugh Rich (Corporate Broking)
Camarco (Financial PR)	Tel: +44 (0)20 3757 4992
Ginny Pulbrook / Rosie Driscoll

 

Notes to Editors:

AMTE Power was founded in 2013 and is a leading developer and manufacturer of lithium-ion and sodium-ion battery cells for specialist markets. In March 2021, the Company was admitted to trading on the AIM market of the London Stock Exchange. The Company is focused on launching a series of next generation battery cells based on new chemistries and cell structures that are designed to solve key problems in power delivery, energy performance, and safety. These new products are targeted at a range of specialist markets including the electric vehicle industry and energy storage sector. 

 

AMTE Power's purpose-built cell manufacturing facility in Thurso, Scotland has the second largest cell manufacturing capacity in the UK and the Company also has a product development team based in Oxford. AMTE's proposed state-of-the-art MegaFactory in Dundee, Scotland is expected to be operational and in production by Q3 2025 and will be capable of producing over 25,000 high added value batteries per day enabling the Company to rapidly scale up cell production.

 

For further information visit the Company's website:  www.amtepower.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

CNTBKPBNABDDKKK

Close

×

RNS Number : 6141B

N4 Pharma PLC

04 October 2022

 

 

4 October 2022

 

N4 Pharma Plc

("N4 Pharma" or the "Company")

Double siRNA Testing Update

N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing Nuvec®, a novel delivery system for cancer treatments and vaccines, is pleased to announce successful in vitro testing of Nuvec® loaded with two small interfering RNA (siRNA) probes.

 

On 14 September 2022, the Company announced a strategic update highlighting its intention to focus its further development work on multiple loaded siRNA on Nuvec®.

T he Company has now completed initial in vitro testing of Nuvec® loaded with two generic siRNA probes, GFP (Green Fluorescent protein) and EHMT-2 (Euchromatic Histone Lysine Methyltransferase 2 ) at the same time. The siRNA probes were loaded onto Nuvec® in equal amounts, at a concentration previously shown to be active. Testing demonstrated that both siRNA probes when loaded onto Nuvec® were able to significantly silence their respective targets.

 

 

Nigel Theobald, Chief Executive Officer of the Company, commented :

 

"Showing that Nuvec® loaded with two generic siRNA probes still achieves significant silencing of their respective genes is validation for us to now begin the further work that we announced on 14 September with EGFR and BCl-2 in a PC9 lung cancer model.

 

"Achieving the initial successful testing of Nuvec ® with the generic GFP and EHMT-2 siRNA will also allow us to commence commercial outreach discussions which will only be further strengthened by the results from the new work we are undertaking ."

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 which has been incorporated into UK law by the European Union (Withdrawal) Act 2018.  

 

 

Enquiries:

 

N4 Pharma Plc Nigel Theobald, CEO Luke Cairns, Executive Director	Via IFC Advisory
SP Angel Corporate Finance LLP Nominated Adviser and Joint Broker Matthew Johnson/Caroline Rowe (Corporate Finance) Vadim Alexandre/Rob Rees (Corporate Broking)	Tel: + 44 (0)20 3470 0470
IFC Advisory Limited Financial PR Graham Herring Zach Cohen	Tel: +44 (0)20 3934 6630

 

 

About N4 Pharma

N4 Pharma is a specialist pharmaceutical company developing a novel delivery system for cancer and vaccine treatments using its unique silica nanoparticle delivery system called Nuvec®.

N4 Pharma's business model is to partner with companies developing novel antigens for cancer and vaccine treatments to use Nuvec® as the delivery vehicle to get their antigen into cells to express the protein needed for the required immunity. As these products progress through pre clinical and clinical programs, N4 Pharma will seek to receive up front payments, milestone payments and ultimately royalty payments once products reach the market.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

MSCMJBATMTJMBTT

Close

×

RNS Number : 6037B

S-Ventures PLC

04 October 2022

 

4 October 2022

 

S-VENTURES PLC

("S-Ventures" or the "Company")

AQSE Ticker Code: SVEN

New contract wins

S-Ventures PLC, the Company investing in and growing exciting brands across the natural, wellness and food-tech category, is pleased to announce new contract wins from its Pulsin, Purely, Ohso and Livia's product ranges.

ASDA has recently partnered with S-Ventures and has given Pulsin branded space within their brand partnership programme to showcase the brand in six ASDA flagship stores.

This follows the launch of the Pulsin Keto range in the Health & Wellbeing fixture in 200 Morrison stores in Spring of this year.

In Holland & Barrett UK Stores, Pulsin has increased its store distribution on their protein powders range by over 2,000 distribution points, which goes live this month. They also launched the latest flavoured protein powder, the Vanilla & Faba protein powder in over 300 stores.

As well as supporting Pulsin, the food team at Holland & Barrett UK have also listed the Purely brand, listing the 28g impulse bags at front of store locations.

Further afield, Holland & Barrett Benelux have really supported S-Ventures, with the Pulsin Orange Keto Bars now listed within stores, as well as the 75g Purely sharing bags now available within the food section.

Co-op has been revamping its ranges in their Healthy Snacking fixtures and will see an increase in Pulsin distribution of their Keto range as well as launching a Pulsin brownie range.

In WH Smiths:

· Purely 75g recently went live in over 100 travel sites;

· Pulsin went live in February 2022 with the brownie range featuring within their "meal deal" solution; and

· OhSo went live in May featuring Ohso's "block" chocolate fixture.

 

Epicurum Wholesale has launched Pulsin, Purely & Livias which are now all live.

At Blakemore/The Vegan Store, it is in the process of going live across all S-Ventures brands.

Pulsin is now live within the two major retailers, S-Ok and more recently Kesko, in Finland.

Easyjet has selected Livia's Nugglets for its inflight menu for the Summer / Autumn 2022 period.

Valli Forecourts agreed to go live with Pulsin in their forecourts in the Summer 2022, offering a range of Keto Bars, Protein Bars and Brownies.

CEO, Scott Livingston, Statement:

"These significant contract wins with major brand names, demonstrate the rapid progress S-Ventures is making establishing itself in the UK and in Europe. Our focus on quality across our product range underpins our success and we look forward to further progress in the coming months."

 

For further information, please contact:

The Company Robert Hewitt (Chief Financial Officer) Scott Livingston (Chief Executive Officer)	+44 (0) 1932 400 224
AQSE Corporate Adviser and Broker: VSA Capital Limited Andrew Raca – Corporate Finance Andrew Monk – Corporate Broking	+44 (0) 20 3005 5000
IFC Advisory (Financial PR) Graham Herring Tim Metcalfe Florence Chandler	+44 (0) 20 3934 6630

 

About S-Ventures

S-Ventures is listed on UK AQUIS Exchange (Ticker Code "SVEN"). The Company seeks to identify investment opportunities in the health & wellness, organic food and wellbeing sectors within the UK and Europe, adding value by providing capital and expertise to the target companies. The experience and operational skills of the Board led by Scott Livingston (CEO) are intended to act as an accelerator to smaller brands that have a solid foundation and platform but may lack the skills and capital. The main objectives are to cross-fertilise opportunities between the target companies and scale the individual entities and look for exit opportunities and/or synergistic collaborations through scaling we seek to create significant value for all stakeholders. Since listing on AQSE in September 2020, the Company has acquired significant interests in seven companies.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

NEXUOASRUOURRAA

Close